C. Berger

885 total citations
10 papers, 640 citations indexed

About

C. Berger is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Berger has authored 10 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Berger's work include Testicular diseases and treatments (3 papers), Cancer Treatment and Pharmacology (2 papers) and Cancer Diagnosis and Treatment (2 papers). C. Berger is often cited by papers focused on Testicular diseases and treatments (3 papers), Cancer Treatment and Pharmacology (2 papers) and Cancer Diagnosis and Treatment (2 papers). C. Berger collaborates with scholars based in Germany, France and Belgium. C. Berger's co-authors include Hans‐Joachim Schmoll, Carsten Bokemeyer, M. Kuczyk, Lothar Kanz, Christian Kollmannsberger, Frank Schuppert, M.C. Demaille, F Pein, Jean Claude Gentet and C Kalifa and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and British Journal of Cancer.

In The Last Decade

C. Berger

9 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Berger Germany	7	261	208	154	137	128	10	640
M. Kuczyk Germany	4	221 0.8×	181 0.9×	108 0.7×	134 1.0×	95 0.7×	10	543
Robert J. Hamilton United States	9	225 0.9×	166 0.8×	101 0.7×	126 0.9×	93 0.7×	12	513
Yoriko Murata Japan	13	64 0.2×	75 0.4×	88 0.6×	32 0.2×	64 0.5×	44	646
Shunichi Matsumoto Japan	19	286 1.1×	163 0.8×	162 1.1×	9 0.1×	189 1.5×	83	1.1k
K. H. Schicketanz Germany	8	48 0.2×	99 0.5×	62 0.4×	41 0.3×	117 0.9×	18	417
C Asteria Italy	15	253 1.0×	33 0.2×	36 0.2×	16 0.1×	200 1.6×	36	1.1k
Frédéric Mercier France	17	533 2.0×	71 0.3×	208 1.4×	7 0.1×	133 1.0×	48	841
Ra Gyoung Yoon South Korea	15	137 0.5×	40 0.2×	94 0.6×	31 0.2×	26 0.2×	32	495
Eddie Myers Ireland	11	244 0.9×	169 0.8×	65 0.4×	115 0.8×	131 1.0×	19	624
Davide Giordano Italy	15	460 1.8×	97 0.5×	145 0.9×	22 0.2×	132 1.0×	43	942

Countries citing papers authored by C. Berger

Since Specialization

Citations

This map shows the geographic impact of C. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Berger more than expected).

Fields of papers citing papers by C. Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Berger. The network helps show where C. Berger may publish in the future.

Co-authorship network of co-authors of C. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of C. Berger. A scholar is included among the top collaborators of C. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Berger. C. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Bokemeyer, Carsten, C. Berger, Christian Kollmannsberger, et al.. (1998). Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. British Journal of Cancer. 77(8). 1355–1362. 248 indexed citations

Chauvet, B., et al.. (1998). [Treatment of infiltrating cancer of the bladder with cisplatin, fluorouracil, and concurrent radiotherapy: results of a pilot study].. PubMed. 2 Suppl 1. 77s–81s. 5 indexed citations

Bokemeyer, Bernd, C. Berger, Jakob Hartmann, et al.. (1998). Analysis of Risk Factors for Cisplatin-Induced Ototoxicity in Patients With Testicular Cancer. The Journal of Urology. 160(6 Part 1). 2292–2293. 4 indexed citations

Gentet, Jean Claude, M Brunat-Mentigny, M.C. Demaille, et al.. (1997). Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the french society of paediatric oncology. European Journal of Cancer. 33(2). 232–237. 55 indexed citations

Bokemeyer, Carsten, C. Berger, M. Kuczyk, & Hans‐Joachim Schmoll. (1996). Evaluation of long-term toxicity after chemotherapy for testicular cancer.. Journal of Clinical Oncology. 14(11). 2923–2932. 199 indexed citations

Berger, C., Carsten Bokemeyer, Frank Schuppert, & Hans‐Joachim Schmoll. (1996). Endocrinological late effects after chemotherapy for testicular cancer. British Journal of Cancer. 73(9). 1108–1114. 49 indexed citations

Chauvet, B., et al.. (1996). [Prostate specific antigen (PSA): impact of a seric marker on the diagnosis and therapeutic management of cancers of the prostate].. PubMed. 83(4). 334–44.

Berger, C., et al.. (1995). Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer. European Journal of Cancer. 31(13-14). 2229–2238. 67 indexed citations

Reynaud-Bougnoux, A., Philippe Mercier, P. Descamps, et al.. (1995). 73 Post-operative radiotherapy and concomitant adjuvant chemotherapy for breast carcinoma. European Journal of Cancer. 31. S16–S17. 6 indexed citations

10.

Bokemeyer, Carsten, C. Berger, B. Kynast, Hans‐Joachim Schmoll, & H. Poliwoda. (1993). Ototoxicity following therapy for testicular cancer. European Journal of Cancer. 29. S241–S241. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact